Evidence map›Paper›PMID 39561226›Full record

ReviewCirculation. Cardiovascular imaging2024

Current and Emerging Approaches to Imaging Large Vessel Vasculitis.

Ahmed Tawakol, Brittany Nicole Weber, Michael T Osborne, Mark A Matza, Vinit Baliyan, Ana Belen Arevalo Molina, Hui Chong Lau, Pedram Heidari, Jan Bucerius, Zachary S Wallace and 2 more

Abstract readReview
In one paragraph

Review in Circulation. Cardiovascular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed TawakolCardiology Division and the Cardiovascular Imaging Research Center (A.T., M.T.O., H.C.L.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0002-9211-5483
Brittany Nicole WeberDivision of Cardiovascular Imaging, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (B.N.W.).ORCID 0000-0002-0177-2091
Michael T OsborneCardiology Division and the Cardiovascular Imaging Research Center (A.T., M.T.O., H.C.L.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0003-1001-1718
Mark A MatzaRheumatology Unit (M.A.M., A.B.A.M., Z.S.W., S.U.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0001-6566-0040
Vinit BaliyanDepartment of Imaging (V.B., P.H., S.H.), Massachusetts General Hospital and Harvard Medical School, Boston.
Ana Belen Arevalo MolinaRheumatology Unit (M.A.M., A.B.A.M., Z.S.W., S.U.), Massachusetts General Hospital and Harvard Medical School, Boston.
Hui Chong LauCardiology Division and the Cardiovascular Imaging Research Center (A.T., M.T.O., H.C.L.), Massachusetts General Hospital and Harvard Medical School, Boston.
Pedram HeidariDepartment of Imaging (V.B., P.H., S.H.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0001-6383-465X
Jan BuceriusDepartment of Nuclear Medicine, University Medical Centre of Gottingen, Germany (J.B.).
Zachary S WallaceRheumatology Unit (M.A.M., A.B.A.M., Z.S.W., S.U.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0003-4708-7038
Sandeep HedgireDepartment of Imaging (V.B., P.H., S.H.), Massachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0001-8527-9386
Sebastian UnizonyRheumatology Unit (M.A.M., A.B.A.M., Z.S.W., S.U.), Massachusetts General Hospital and Harvard Medical School, Boston.

Funding

Translational imaging and nanomedicine in inflammatory atherosclerosisP01HL131478 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Zahi A. Fayad · 2017 to 2026
$24.3M
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV InfectionR01HL152957 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER W HUNT, Priscilla Y. Hsue · 2020 to 2026
$3.7M
Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation, Cardiometabolic Disease, and Treatment Response in Rheumatoid ArthritisR01AR077187 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JON T GILES, AHMED A TAWAKOL · 2021 to 2026
$2.3M
Targeting T cell Subsets in Autoimmune DiseaseUM1AI144295 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI John H Stone · 2019 to 2026
$1.4M
Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulationK08CA249047 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HEIDARI, PEDRAM · 2020 to 2024
$1.3M
The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease: A Multi-System PET/MRI StudyK23HL151909 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI OSBORNE, MICHAEL THOMAS · 2021 to 2025
$997k
Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasisK23HL159276 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI WEBER, BRITTANY NICOLE · 2021 to 2025
$962k
Neuroimaging Measures of Psychological Distress as Predictors of Articular and Arterial Inflammation and Treatment Response in Rheumatoid ArthritisR56AR077187 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GILES, JON T, TAWAKOL, AHMED A · 2020 to 2020
$555k
NCI NIH HHS K08 CA249047NHLBI NIH HHS K23 HL151909NHLBI NIH HHS K23 HL159276NHLBI NIH HHS P01 HL131478NHLBI NIH HHS R01 HL152957NIAID NIH HHS UM1 AI144295NIAMS NIH HHS R01 AR077187NIAMS NIH HHS R56 AR077187
6 · The paper itself

Abstract

Large vessel vasculitides (LVV) comprise a group of inflammatory disorders that involve the large arteries, such as the aorta and its primary branches. The cause of LVV is often rheumatologic and includes giant cell arteritis and Takayasu arteritis. Giant cell arteritis is the most common form of LVV affecting people >50 years of age with a slight female predominance. Takayasu arteritis is more frequently seen in younger populations and is significantly more common in women. Prompt identification of LVV is crucial as it can lead to debilitating complications if left untreated, including blindness in the case of giant cell arteritis and large artery stenosis and aneurysms in the case of all forms of LVV. Noninvasive imaging methods have greatly changed the approach to managing LVV. Today, imaging (with ultrasound, magnetic resonance imaging, computed tomography, and positron emission tomography) is routinely used in the diagnosis of LVV. In patients with giant cell arteritis, imaging often spares the use of invasive procedures such as temporal artery biopsy. In addition, vascular imaging is also crucial for longitudinal surveillance of arterial damage. Finally, imaging is currently being studied for its role in assessing treatment response and ongoing disease activity and its potential value in determining the presence of vascular wall remodeling (eg, scarring). This review explores the current uses of noninvasive vascular imaging in LVV.

Indexed as

Giant Cell ArteritisTakayasu ArteritisFemaleHumansPredictive Value of TestsPrognosisaortaComputed tomographygiant cell arteritismagnetic resonance imagingpositron-emission tomographyTakayasu arteritis

Identifiers

PMID39561226
PMCPMC11619766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.